TG Pharma (TGTX) - כמות מזומנים למניה

The cash per share value provided by the GURU.Markets website shows that the metric level is 3.32. Risks are linked to single-product dependency and pressure from corporate behemoths. However, targeted therapy creates a steady cash flow due to chronic diagnoses. Meanwhile, the high efficacy of the flagship drug helps TG Therapeutics, Inc. (TGTX) successfully expand its presence in the multiple sclerosis segment.
פילוחים אנליטיים של חברת TG Therapeutics, Inc.

This indicator determines asset liquidity by calculating the share of available cash per ordinary share to assess financial resilience. Analyzing the cash cushion per share reveals the ability of TG Therapeutics (TGTX) to fund complex last-mile logistics and hub maintenance, which is critical for maintaining the quality of targeted drugs while scaling supplies.